Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Eloxx Pharmaceuticals, Inc. (ELOX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Jun-30-17Dec-31-16
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.00.00.0
            Revenue growth        -100.0% 
Cost of goods sold  0.00.00.00.00.00.02.60.0
Gross profit  0.00.00.00.00.00.0-2.60.0
            Gross margin          
Selling, general and administrative   [+]10.720.414.824.226.52.71.40.9
Research and development  23.722.914.626.320.516.40.79.0
Other operating expenses      0.61.3  
EBITDA   [+]  -29.4-50.5-47.3-20.4-4.7-9.8
            EBITDA margin          
Depreciation and amortization    0.10.10.20.00.00.0
EBIT   [+]-34.4-43.3-29.4-50.6-47.6-20.4-4.7-9.8
            EBIT margin          
Non-recurring items   [+] 22.74.0   -0.1 
Interest income, net   [+]0.30.00.31.10.6 -0.3 
Other income (expense), net   [+]-1.9-0.7-1.5-1.4-0.1-0.8-2.00.0
Pre-tax income  -36.1-66.7-34.6-50.9-47.1-21.2-6.8-9.8
Income taxes  0.00.00.00.00.10.0-1.00.0
            Tax rate  0.0%0.0%0.0%0.0% 0.0%15.2%0.0%
Net income  -36.1-66.7-34.6-50.9-47.2-23.6-6.2-10.9
            Net margin          
   
Basic EPS   [+]($16.65)($38.15)($0.86)($1.34)($1.45)($4.75)($0.27)($2.60)
Diluted EPS   [+]($16.65)($38.15)($0.86)($1.34)($1.45)($4.75)($0.27)($2.60)
   
Shares outstanding (basic)   [+]2.21.740.138.132.45.023.24.2
Shares outstanding (diluted)   [+]2.21.740.138.132.45.023.24.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy